CELL INTELLIGENCE · 肿瘤细胞治疗研究

胶质母细胞瘤的下一代治疗：挑战与未来方向

Next-generation therapeutics for glioblastoma: Challenges and future directions.

通过编码双特异性 T 细胞衔接器的溶瘤腺病毒改造微环境以实现胶质母细胞瘤中的 CAR-T 细胞免疫治疗

Enable CAR T cell immunotherapy in glioblastoma by modifying its microenvironment via oncolytic adenovirus encoding bispecific T cell engager.

胶质母细胞瘤：流行病学、分类、发病机制、诊断与治疗的当代概述——综述文章

Glioblastoma-A Contemporary Overview of Epidemiology, Classification, Pathogenesis, Diagnosis, and Treatment: A Review Article.

T-SIGn 肿瘤重编程治疗与 CAR-T 细胞在联合治疗中协同清除 NSG 小鼠中的人肺肿瘤异种移植与肺转移

T-SIGn tumor reengineering therapy and CAR T cells synergize in combination therapy to clear human lung tumor xenografts and lung metastases in NSG mi

胶质母细胞瘤的新兴疗法

Emerging therapies for glioblastoma.

高级别胶质瘤的免疫治疗与靶向治疗：当前与未来方向

Immunotherapy and targeted therapy for high grade gliomas: current and future directions.

高级别胶质瘤是一种网络性疾病，涉及众多相互关联的分子和微环境现象，从肿瘤内在通路和抗原性到免疫识别与攻击，再到神经元对肿瘤和免疫信号的调控。新兴疗法通常同时利用其中若干交叉机制，为这些毁灭性癌症的未来临床治疗带来了希望。不适用。

胶质母细胞瘤：针对其病理生理、治疗与创新治疗策略的多学科方法

Glioblastoma: A Multidisciplinary Approach to Its Pathophysiology, Treatment, and Innovative Therapeutic Strategies.

勘误：基于配体、piggyBac 工程化的靶向 EGFR 的 CAR-T 细胞对非小细胞肺癌安全有效

Erratum: Ligand-based, piggyBac-engineered CAR-T cells targeting EGFR are safe and effective against non-small cell lung cancers.

基于配体、piggyBac 工程化的靶向 EGFR 的 CAR-T 细胞对非小细胞肺癌安全有效

Ligand-based, piggyBac-engineered CAR-T cells targeting EGFR are safe and effective against non-small cell lung cancers.

CXCR5 引导抗 EGFR CAR-T 细胞的迁移与肿瘤清除

CXCR5 guides migration and tumor eradication of anti-EGFR chimeric antigen receptor T cells.